MONTREAL – Travelers departing from Trudeau Airport may soon be required to take a COVID-19 test at $ 149 before leaving for destinations that require a negative test certificate.
The authority in charge of Montreal airports (ADM) and the Biron Groupe Sante laboratories announced on Monday the launch of a new pilot project aimed at testing “a new rapid screening process” at the Trudeau airport terminal for passengers to mainland France. Entering France now requires proof of a negative test.
The antigenic tests will allow a “certified and rapid” analysis which can be carried out in 15 minutes.
The new service will be offered by reservation from December 15 to travelers going to France via Air Canada, Air France, KLM or Air Transat, ADM said in a statement. The nasal sample will be taken “in a space provided for this purpose in the terminal… by professionals from Biron”.
ADM stated that the antigen test used by Biron is approved by Health Canada and recognized in France. Only passengers authorized to travel to France will be able to make an appointment during the pilot project.
The initial pilot project will last eight weeks. According to ADM, it complies with the recommendations of the International Air Transport Association and the guidelines of the International Civil Aviation Organization for stringent control measures.
ADM CEO Philippe Rainville said the pilot project was being rolled out to complement existing measures such as temperature control and sanitary checkpoints erected at three of the terminal entrances.
“It is essential to ensure the relaunch of travel that other initiatives are put forward by airports, carriers and public health teams,” he said.
Another pilot project, launched in November, allows travelers to Calgary to reduce their quarantine period by taking a rapid drug test. If the test is negative, they are allowed to end their isolation period after one week, rather than the two necessary.
– This report by The Canadian Press was first published on December 7, 2020.